Current Rating and Its Implications
The Strong Sell rating assigned to Dishman Carbogen Amcis Ltd indicates a cautious stance for investors, suggesting that the stock is expected to underperform relative to the broader market and sector peers. This rating is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment appeal and risk profile.
Quality Assessment
As of 01 August 2026, the company’s quality grade remains below average. This reflects concerns about its operational efficiency and long-term fundamental strength. The average Return on Capital Employed (ROCE) stands at a modest 1.18%, signalling limited profitability relative to the capital invested. Additionally, while net sales have grown at an annual rate of 8.93% over the past five years, this growth rate is not sufficiently robust to offset other weaknesses in the business model. Investors should note that a below-average quality grade often points to challenges in sustaining competitive advantage or generating consistent earnings growth.
Valuation Perspective
Interestingly, the valuation grade for Dishman Carbogen Amcis Ltd is classified as very attractive. This suggests that, based on current price levels and earnings expectations, the stock may be undervalued relative to its intrinsic worth or sector benchmarks. For value-oriented investors, this could represent a potential opportunity to acquire shares at a discount. However, valuation alone does not guarantee positive returns, especially when other fundamental and technical factors are unfavourable.
Financial Trend Analysis
The financial trend for the company is negative, reflecting deteriorating profitability and balance sheet pressures. The latest quarterly results for March 2026 reveal a significant decline in profit after tax (PAT), which fell by 59.4% to ₹22.28 crores. The debt-equity ratio has also increased, reaching 0.46 times in the half-year period, indicating a higher reliance on debt financing. Moreover, the Debt to EBITDA ratio is elevated at 5.44 times, highlighting potential challenges in servicing debt obligations. Non-operating income constitutes 34.73% of profit before tax, which may raise concerns about the sustainability of earnings from core operations. These factors collectively contribute to the negative financial grade and weigh heavily on the stock’s outlook.
Technical Evaluation
From a technical standpoint, the stock is mildly bearish. While short-term price movements show some positive momentum—with a 1-day gain of 1.35%, a 1-week increase of 2.12%, and a 1-month rise of 6.97%—the medium to long-term trends are less encouraging. Over the past six months, the stock has declined by 13.86%, and year-to-date returns stand at -24.18%. The one-year return is similarly negative at -25.15%, underperforming the BSE500 index over comparable periods. This technical backdrop suggests that despite occasional rallies, the stock remains under pressure and may continue to face downward momentum.
Here’s How the Stock Looks Today
As of 01 August 2026, Dishman Carbogen Amcis Ltd is characterised by weak long-term fundamental strength, negative financial trends, and a mildly bearish technical outlook. The company’s operational challenges and elevated debt levels have contributed to subdued profitability and investor caution. Although the valuation appears attractive, this alone does not offset the risks posed by deteriorating earnings and balance sheet concerns.
Investors considering this stock should weigh the potential for value against the evident risks. The Strong Sell rating reflects a consensus that the stock is likely to underperform in the near to medium term, and caution is advised. For those with a higher risk tolerance, monitoring the company’s efforts to improve operational efficiency and reduce leverage will be critical before reassessing the investment case.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Sector and Market Context
Dishman Carbogen Amcis Ltd operates within the Pharmaceuticals & Biotechnology sector, a space often characterised by high research and development costs, regulatory challenges, and competitive pressures. The company’s small-cap status adds an additional layer of volatility and liquidity considerations for investors. Compared to sector peers, Dishman Carbogen Amcis Ltd’s performance and financial health lag behind, as reflected in its below-average quality grade and negative financial trend.
Investor Takeaway
For investors, the Strong Sell rating serves as a clear signal to exercise caution. While the stock’s valuation may appear enticing, the underlying fundamentals and financial health present significant headwinds. The company’s weak profitability, high leverage, and underwhelming returns relative to the broader market suggest that the risk-reward balance currently favours a defensive approach.
Investors seeking exposure to the Pharmaceuticals & Biotechnology sector might consider alternatives with stronger quality metrics and more favourable financial trends. Monitoring Dishman Carbogen Amcis Ltd for any meaningful improvements in operational efficiency, debt reduction, or earnings growth will be essential before revisiting its investment potential.
Summary of Key Metrics as of 01 August 2026
- Mojo Score: 23.0 (Strong Sell)
- Market Capitalisation: Small Cap
- Return on Capital Employed (ROCE): 1.18%
- Net Sales Growth (5-year CAGR): 8.93%
- Debt to EBITDA Ratio: 5.44 times
- Debt-Equity Ratio (Half Year): 0.46 times
- Profit After Tax (Q4 Mar 2026): ₹22.28 crores, down 59.4%
- Non-operating Income as % of PBT: 34.73%
- Stock Returns: 1D +1.35%, 1W +2.12%, 1M +6.97%, 6M -13.86%, YTD -24.18%, 1Y -25.15%
These figures collectively underpin the current Strong Sell rating and highlight the challenges facing Dishman Carbogen Amcis Ltd in the current market environment.
Conclusion
Dishman Carbogen Amcis Ltd’s Strong Sell rating by MarketsMOJO, last updated on 04 February 2026, reflects a comprehensive assessment of its below-average quality, very attractive valuation, negative financial trend, and mildly bearish technical outlook. As of 01 August 2026, the company continues to face significant operational and financial challenges, which have translated into disappointing stock performance and investor sentiment. While the valuation may attract some interest, the overall risk profile suggests that investors should approach this stock with caution and consider alternative opportunities within the sector or broader market.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
